IAS
<ѻý class="page-description">IAS Conference on HIV Scienceѻý>Greater risk for mpox hospitalization, death in immunosuppressed people living with HIV
Mortality rates among hospitalized patients were 20% versus 10% for people without HIV
But this case is unique, researchers say
Reduction in MACE did not come with serious adverse events
"These data provide a powerful opportunity to destigmatize HIV," researchers say
Cabotegravir wins by a mile to prevent HIV infection
Voluntary medical procedure offers another option for prevention
Some factors more important than others for HIV prevention
Adherence to these HIV preventive measures should be encouraged
PrEP rollout programs need to check for acute infections before starting therapy, experts advise
Interim analysis of small open-label trial finds adverse outcomes are rare
Real-world study showed fewer HIV infections with event-driven regimen
Multi-arm trial suggests the antibiotic can be reduced in three-drug combo
WHO analysis also shows higher risk for inhospital mortality
-
IAC: International AIDS Conference
July 2024
-
IAS: IAS Conference on HIV Science
July 2023
-
ANAC: Association of Nurses in AIDS Care
November 2019
-
HIV Glasgow: The International Congress on Drug Therapy in HIV Infection
October 2018